TY  - RPRT
TI  - Engineering monoclonal antibodies to determine the structural requirements for complement activation and complement mediated lysis.
AU  - I Sandlie
AU  - T E Michaelsen
PY  - 1991
DO  - 10.1016/0161-5890(91)90038-l
UR  - https://pubmed.ncbi.nlm.nih.gov/1749385/
ID  - 1749385
ER  -